Skip to main content
ConductScienceScienceDex

Benjamin Izar

NIH Rank #6303
Unclaimed recordClaim profile
  • Program Leader
  • R01 Holder
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 14551452Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Internal Medicine

NIH Funding · FY2024

Linked Award Amount
$1.8M
Full award amounts, FY2024
Award Records
5
Records listing this PI
Award-Linked Rank
#6,303
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Benjamin Izar. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Benjamin Izar as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA280414-02R01
    Multi-cellular interactions defining the human brain metastatic niche
    Columbia University
    $657.8K
    award amount
  • 5R01CA266446-03R01
    The role of the CD58:CD2 axis in cancer immune evasion and resistance to immunotherapy
    Columbia University
    $388.3K
    award amount
  • 5R37CA258829-04R37
    Mechanisms of liver metastasis and associated resistance to immunotherapy
    Columbia University
    $383.3K
    award amount
  • 5U54CA274506-02U54
    Center for Cancer Systems Therapeutics (CaST)
    Columbia University
    $259.7K
    award amount
  • 3R37CA258829-04S1R37
    Mechanisms of liver metastasis and associated resistance to immunotherapy
    Columbia University
    $137.7K
    award amount

Award organization

Organizations that administered FY2024 awards listing Benjamin Izar as a PI.

FY2024 award administered by Columbia University (NY).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Columbia University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #6303
  5. 2025
    $2M Cumulative Funding
  6. 2025
    R01 Grant Holder
  7. 2025
    Program/Center Grant Leader
  8. 2026
    $5M Cumulative Funding
  9. 2026
    Entered Top 25% Nationally
    Ranked #2046

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Benjamin Izar.

Ashley Marie Laughney
Columbia University
3
shared awards
Andrea Califano
Columbia University
2
shared awards
Barry H Honig
Columbia University
2
shared awards
Diana Murray
Columbia University
2
shared awards
Peter Alan Sims
Columbia University
2
shared awards
Joshua D. Milner
Columbia University
1
shared award

Explore further

Find collaborators for Benjamin Izar

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →
Benjamin Izar | NIH Award Records | ConductScience